CTXR double bottom Long

Citius Pharmaceuticals, Inc.NASDAQ

Description

⋅ May 3, 2021 2:20 PM

Big resistance at 2.53 for CTXR. Hopefully phase 3 talk soon will be the catalyst to cross that.

Could be a nice swing. Target 3$ a share.

This is not financial advice. Do your own DD. Your capital is at risk.